高收入国家多种维生素使用与不良出生结局:系统综述与荟萃分析
该系统综述与荟萃分析纳入35项研究、98,926名高收入国家女性,评估妊娠期使用多种维生素与不良出生结局的关联。多种维生素使用未改变早产风险(RR 0.84,95%CI 0.69-1.03),但降低小于胎龄儿、神经管缺陷、心血管缺陷、尿路缺陷和肢体缺陷风险。除神经管缺陷复发为中等质量证据外,其余结局证据质量低或极低,作者建议谨慎推荐常规使用。
要点
- 多种维生素使用未显著改变早产风险(RR 0.84,95%CI 0.69-1.03)。
- 多种维生素使用降低小于胎龄儿(RR 0.77,95%CI 0.63-0.93)及神经管缺陷(RR 0.67,95%CI 0.52-0.87)风险。
- 除神经管缺陷复发为中等质量证据外,其余结局证据质量低或极低。
核心结论
- 在高收入国家可谨慎推荐常规使用多种维生素,但证据质量低。
- 需要随机对照试验或实施良好的大型前瞻性队列研究。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Embase、Cochrane、Scopus和CINAHL从建库至2016年6月17日。
- 纳入35项在高收入国家进行的研究,共98,926名女性。
- 纳入标准为研究多种维生素(片剂或胶囊中含3种或以上维生素或矿物质)使用与不良出生结局的关联。
- 随机对照试验用Cochrane协作工具评估,观察性研究用纽卡斯尔-渥太华量表评估。
- 对至少2项研究有数据的结局基于原始数据进行荟萃分析,使用RevMan(版本5.3),采用随机效应模型合并,证据质量用GRADE方法评估。
主要发现
- 多种维生素使用未改变主要结局早产的风险(RR 0.84,95%CI 0.69-1.03)。
- 多种维生素使用降低小于胎龄儿风险(RR 0.77,95%CI 0.63-0.93)。
- 多种维生素使用降低神经管缺陷风险(RR 0.67,95%CI 0.52-0.87)。
- 多种维生素使用降低心血管缺陷风险(RR 0.83,95%CI 0.70-0.98)、尿路缺陷风险(RR 0.60,95%CI 0.46-0.78)和肢体缺陷风险(RR 0.68,95%CI 0.52-0.89)。
- 35项研究中仅4项为随机对照试验;除神经管缺陷复发为中等质量证据外,所有结局的GRADE证据质量低或极低。
关键数值与推荐
- 多种维生素定义为片剂或胶囊中含3种或以上维生素或矿物质。
- 无研究比较叶酸加铁与多种维生素的使用。
- 早产:RR 0.84(95%CI 0.69-1.03),未达统计学显著。
- 小于胎龄儿:RR 0.77(95%CI 0.63-0.93)。
- 神经管缺陷:RR 0.67(95%CI 0.52-0.87);心血管缺陷:RR 0.83(95%CI 0.70-0.98);尿路缺陷:RR 0.60(95%CI 0.46-0.78);肢体缺陷:RR 0.68(95%CI 0.52-0.89)。
临床怎么用
- 作者认为在高收入国家可谨慎推荐常规使用多种维生素,但证据质量低。
- 作者建议需要随机对照试验或实施良好的大型前瞻性队列研究。
局限性
- 35项研究中仅4项为随机对照试验。
- 除神经管缺陷复发为中等质量证据外,所有结局的GRADE证据质量低或极低。
- 作者结论指出需要随机对照试验或实施良好的大型前瞻性队列研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In high-income countries, a healthy diet is widely accessible. However, a change toward a poor-quality diet with a low nutritional value in high-income countries has led to an inadequate vitamin intake during pregnancy. OBJECTIVE: We conducted a systematic review and meta-analysis to evaluate the association between multivitamin use among women in high-income countries and the risk of adverse birth outcomes (preterm birth [primary outcome], low birthweight, small for gestational age, stillbirth, neonatal death, perinatal mortality, and congenital anomalies without further specification). STUDY DESIGN: We searched electronic databases (MEDLINE, Embase, Cochrane, Scopus, and CINAHL) from inception to June 17, 2016, using synonyms of pregnancy, study/trial type, and multivitamins. Eligible studies were all studies in high-income countries investigating the association between multivitamin use (3 or more vitamins or minerals in tablets or capsules) and adverse birth outcomes. We evaluated randomized, controlled trials using the Cochrane Collaboration tool. Observational studies were evaluated using the Newcastle-Ottawa Scale. Meta-analyses were applied on raw data for outcomes with data for at least 2 studies and were conducted using RevMan (version 5.3). Outcomes were pooled using the random-effect model. The quality of evidence was assessed using the Grades of Research, Assessment, Development and Evaluation approach. RESULTS: We identified 35 eligible studies including 98,926 women. None of the studies compared the use of folic acid and iron vs the use of multivitamins. The use of multivitamin did not change the risk of the primary outcome, preterm birth (relative risk, 0.84 [95% confidence interval, 0.69-1.03]). However, the risk of small for gestational age (relative risk, 0.77 [95% confidence interval, 0.63-0.93]), neural tube defects (relative risk, 0.67 [95% confidence interval, 0.52-0.87]), cardiovascular defects (relative risk, 0.83 [95% confidence interval, 0.70-0.98]), urine tract defects (relative risk, 0.60 [95% confidence interval, 0.46-0.78]), and limb deficiencies (relative risk, 0.68 [95% confidence interval, 0.52-0.89]) was decreased. Of the 35 identified studies, only 4 were randomized, controlled trials. The degree of clinical evidence according to the Grades of Research, Assessment, Development, and Evaluation system was low or very low for all outcomes except for recurrence of neural tube defects in which a moderate degree of clinical evidence was found. CONCLUSION: Routine multivitamin use in high-income countries can be recommended but with caution because of the low quality of evidence. Randomized, controlled trials or well-performed, large prospective cohort studies are needed.
引用
- Wolf HT, Hegaard HK, Huusom LD, et al. Multivitamin use and adverse birth outcomes in high-income countries: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017. PMID: 28377269. doi:10.1016/j.ajog.2017.03.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。